Browsing by Author "Razok, Almurtada"
Now showing items 1-2 of 2
-
Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
Al-Nesf, Maryam A. Y.; Abdesselem, Houari B.; Bensmail, Ilham; Ibrahim, Shahd; Saeed, Walaa A. H.; Mohammed, Sara S. I.; Razok, Almurtada; Alhussain, Hashim; Aly, Reham M. A.; Al Maslamani, Muna; Ouararhni, Khalid; Khatib, Mohamad Y.; Hssain, Ali Ait; Omrani, Ali S.; Al-Kaabi, Saad; Al Khal, Abdullatif; Al-Thani, Asmaa A.; Samsam, Waseem; Farooq, Abdulaziz; Al-Suwaidi, Jassim; Al-Maadheed, Mohammed; Al-Siddiqi, Heba H.; Butler, Alexandra E.; Decock, Julie V.; Mohamed-Ali, Vidya; Al-Ejeh, Fares... more authors ... less authors ( Nature Research , 2022 , Article)COVID-19 complications still present a huge burden on healthcare systems and warrant predictive risk models to triage patients and inform early intervention. Here, we profile 893 plasma proteins from 50 severe and 50 ... -
SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort
Ata, Fateen; Yousaf, Zohaib; Khan, Adeel Ahmad; Razok, Almurtada; Akram, Jaweria; Ali, Elrazi Awadelkarim Hamid; Abdalhadi, Ahmed; Ibrahim, Diaeldin Abdelgalil; Al Mohanadi, Dabia Hamad S.H.; Danjuma, Mohammed I.... more authors ... less authors ( Springer Nature , 2021 , Article)Euglycemic diabetic ketoacidosis (EuDKA) secondary to Sodium-glucose co-transporter-2 inhibitors (SGLT2i) in type 2 diabetes mellitus (T2D) is a rare but increasingly reported phenomenon. Not much is known about the burden ...